Literature DB >> 21059108

Risk factors for cardiovascular disease in renal transplant recipients and strategies to minimize risk.

Lutz Liefeldt1, Klemens Budde.   

Abstract

Cardiovascular disease is the leading cause of death following renal transplantation, and renal transplant patients have a greatly increased cardiac risk compared with the general population. Death with a functioning graft caused by cardiovascular disease also represents a substantial cause of graft loss. Decreased renal function in transplant recipients is a major contributor to increased cardiac risk, both as an independent risk factor and because of its negative effects on hypertension, anemia, left ventricular hypertrophy, and dyslipidemia. Graft loss and diabetes mellitus are also significant risk factors for cardiac death. Although critical for maintaining the transplanted organs, standard immunosuppressants have toxicities that exacerbate cardiac risk. Preservation of renal function, prevention of graft loss, and reductions in cardiovascular risk factors via improvements in both patient management and immunosuppressive therapies constitute critical strategies for optimizing patient and graft survival over the long term.
© 2010 The Authors. Transplant International © 2010 European Society for Organ Transplantation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21059108     DOI: 10.1111/j.1432-2277.2010.01159.x

Source DB:  PubMed          Journal:  Transpl Int        ISSN: 0934-0874            Impact factor:   3.782


  30 in total

Review 1.  Cardiovascular risk factors following renal transplant.

Authors:  Jill Neale; Alice C Smith
Journal:  World J Transplant       Date:  2015-12-24

2.  Restoration of renal function does not correct impairment of uremic HDL properties.

Authors:  Chantal Kopecky; Michael Haidinger; Ruth Birner-Grünberger; Barbara Darnhofer; Christopher C Kaltenecker; Gunther Marsche; Michael Holzer; Thomas Weichhart; Marlies Antlanger; Johannes J Kovarik; Johannes Werzowa; Manfred Hecking; Marcus D Säemann
Journal:  J Am Soc Nephrol       Date:  2014-07-28       Impact factor: 10.121

3.  Impact of comorbidity on outcome in kidney transplant recipients: a retrospective study in Italy.

Authors:  Fabio Fabbian; Alfredo De Giorgi; Fabio Manfredini; Nicola Lamberti; Silvia Forcellini; Alda Storari; Paola Todeschini; Massimo Gallerani; Gaetano La Manna; Dimitri P Mikhailidis; Roberto Manfredini
Journal:  Intern Emerg Med       Date:  2016-03-22       Impact factor: 3.397

Review 4.  Everolimus in kidney transplant recipients at high cardiovascular risk: a narrative review.

Authors:  Ernesto Paoletti; Franco Citterio; Alberto Corsini; Luciano Potena; Paolo Rigotti; Silvio Sandrini; Elisabetta Bussalino; Giovanni Stallone
Journal:  J Nephrol       Date:  2019-04-27       Impact factor: 3.902

5.  Physical activity and risk of cardiovascular events and all-cause mortality among kidney transplant recipients.

Authors:  Augustine W Kang; Andrew G Bostom; Hongseok Kim; Charles B Eaton; Reginald Gohh; John W Kusek; Marc A Pfeffer; Patricia M Risica; Carol E Garber
Journal:  Nephrol Dial Transplant       Date:  2020-08-01       Impact factor: 5.992

6.  Are levels of NT-proBNP and SDMA useful to determine diastolic dysfunction in chronic kidney disease and renal transplant patients?

Authors:  Lidija Memon; Vesna Spasojevic-Kalimanovska; Natasa Bogavac Stanojevic; Jelena Kotur-Stevuljevic; Sanja Simic-Ogrizovic; Vojislav Giga; Violeta Dopsaj; Zorana Jelic-Ivanovic; Slavica Spasic
Journal:  J Clin Lab Anal       Date:  2013-11       Impact factor: 2.352

7.  Prognostic impact of SPECT-MPI after renal transplantation.

Authors:  Wael Abuzeid; Robert M Iwanochko; Xuesong Wang; S Joseph Kim; Mansoor Husain; Douglas S Lee
Journal:  J Nucl Cardiol       Date:  2016-09-23       Impact factor: 5.952

8.  Hypoadiponectinemia correlates with arterial stiffness in kidney transplantation patients.

Authors:  Guan-Jin Ho; Ming-Che Lee; Chung-Jen Lee; Yen-Cheng Chen; Bang-Gee Hsu
Journal:  Clin Exp Nephrol       Date:  2014-07-19       Impact factor: 2.801

9.  Plasma homocysteine and folate levels and dietary folate intake in adolescents and young adults who underwent kidney transplantation during childhood.

Authors:  Ryoko Hamatani; Miki Otsu; Hiroko Chikamoto; Yuko Akioka; Motoshi Hattori
Journal:  Clin Exp Nephrol       Date:  2013-06-04       Impact factor: 2.801

Review 10.  Hypertension after kidney transplantation: a pathophysiologic approach.

Authors:  Beje Thomas; David J Taber; Titte R Srinivas
Journal:  Curr Hypertens Rep       Date:  2013-10       Impact factor: 5.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.